Rare Diseases
Conference Coverage
Ebola outbreak: WHO/OCHA call for more aid, better security
Security, public trust, and a lack of resources are significant barriers to countering the current Ebola epidemic in the Democratic Republic of...
Conference Coverage
Ibrutinib tops chlorambucil against CLL
AMSTERDAM – The Bruton’s tyrosine kinase inhibitor was associated with a halving of risk for death, compared with chlorambucil.
Conference Coverage
CDC: Look for early symptoms of acute flaccid myelitis, report suspected cases
The average age of a patient diagnosed with AFM is 5 years
News
HCC surveillance after anti-HCV therapy cost effective only for patients with cirrhosis
Surveillance twice a year of all patients with F3 or F4 fibrosis had a less than 1% chance of remaining under a $50,000 per QALY willingness-to-...
Conference Coverage
Rozanolixizumab may offer new treatment paradigm for ITP
AMSTERDAM – “Data from this study indicate that we can achieve effective increases in platelet levels, we can observe decreasing IgG levels, and...
News
Budesonide tablets considerably outperformed placebo for active EoE
After 6 weeks, 34 of 59 patients (58%) receiving budesonide orodispersible tablets had achieved complete remission.
Conference Coverage
R2 appears active in high-risk FL and MZL
CHICAGO – R2 produced responses in patients who were refractory to rituximab or both lenalidomide and rituximab at baseline.
Latest News
New tickborne virus emerges in China
A previously unknown RNA segmented virus was associated with a febrile illness that spread to 86 patients.
News
Do You Know Rocky Mountain Spotted Fever When You See It?
The rates of the most severe form of spotted fever rickettsiosis is on the rise, but are health care providers able to recognize it enough to...
News
Pexidartinib gets ODAC nod for tenosynovial giant cell tumor treatment
Missing efficacy data from the pivotal ENLIVEN trial and adverse liver events were points of contention.